- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02805712
Focused Palliative Care Intervention in Advanced Heart Failure
Pilot Study of a Focused Palliative Care Intervention for Recently Hospitalized High-Risk Patients With Heart Failure
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Patients will be assigned to one of two groups a) longitudinal goals of care discussion led by a palliative care-trained social worker or b) usual care + written information regarding advanced directives. The intervention group will be enrolled in the hospital and then be followed longitudinally for 3 months by a palliative care-trained social worker who will shepherd a conversation around prognosis, expectations, and goals of care. The results of these conversations will be documented in the electronic medical record and shared with the clinical team. Clinical symptoms that are identified during these conversations will be evaluated by a Palliative Care Physician who will relay suggestions regarding management to the primary treating clinician. Baseline surveys will assess prognostic awareness, symptom burden, anxiety, depression, and quality of life for both groups. At the conclusion of the study, an individualized follow-up plan will be devised for each patient based on a needs assessment by the study social worker.
Patients assigned to the control/usual care arm will complete the same series of questionnaires as those assigned to the intervention group and will undergo usual in hospital and post-discharge treatment as directed by their care team. All control subjects will receive written Advanced Care planning and Heart Failure education materials as provided routinely to inpatients at Brigham and Women's Hospital. At the 6 month visit following hospitalization, these patients will be asked to complete follow up questionnaires and then will be given the option to participate in the above verbal intervention and guided "Goals and Values" conversation that was provided to the intervention group.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Massachusetts
-
Boston, Massachusetts, Vereinigte Staaten, 02115
- Brigham and Women's Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria
- Symptomatic Heart Failure (NYHA II-IV)
Hospitalized or recently for acute decompensation with at least one of the following high-risk features
- Prior hospitalization for Heart Failure (HF) within 1 year
- Age > 80 years
- Chronic Kidney Disease (estimated Glomerular Filtration Rate (eGFR) < 45 mL/min/m2)
- Systolic Blood Pressure < 100 mm Hg
- Serum sodium < 130 meq/L
- Cardiogenic Shock (Cardiac Index < 2.0)
- Serious Non-Cardiovascular Illness (e.g. advanced stage cancer, Chronic Obstructive Pulmonary Disease (COPD) , or the like.
- Ability to Provide Informed Consent
- Permission of attending physician
Exclusion Criteria
- Anticipated major cardiac surgery, including Ventricular Assist Device (VAD) or transplant, within 3 months of enrollment
- Already enrolled in hospice or receiving outpatient palliative care
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Control
Participant will receive usual care for Heart Failure patients, which include standard written material on Advanced Care planning and supportive cardiology/palliative care consult if ordered by attending.
|
The control group will receive usual written care material and a palliative care consult if ordered by physician.
|
|
Experimental: Verbal Information and Discussion
Participants will participate in a guided goals of care conversation and the support of a Palliative Care Social Worker who is working closely with the patients' primary cardiology team.
Social worker has ongoing clinical review of participants with a Palliative Care physician who will provide a full medical consult if appropriate.
|
Intervention patient will receive a outpatient session with a palliative care social worker in the heart failure clinic two weeks post discharge consent focusing on goals of care.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Is there a change in patient understanding of prognosis with the addition of a palliative care intervention?
Zeitfenster: 6 months
|
Assessment tool: Patient Preferences Questionnaire.
|
6 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Is there an impact on documentation of advanced care planning documentation with a palliative care intervention?
Zeitfenster: 6 months
|
Chart review of Advanced Care Planning documents and written notes by members of clinical team.
|
6 months
|
|
Is there an impact on symptom burden through a palliative care intervention?
Zeitfenster: Three months
|
Assessment tool: : The Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
|
Three months
|
|
Is there an impact on perceived level of illness through a palliative care intervention?
Zeitfenster: 6 months
|
Assessment tool: EQ visual analogue scale (EQ-VAS)
|
6 months
|
|
Is there an impact on overall patient well being through a palliative care intervention?
Zeitfenster: Three months
|
Assessment tool: The Functional Assessment of Chronic Illness Therapy ( FACIT-Sp)
|
Three months
|
|
Is there an impact on depression through a palliative care intervention?
Zeitfenster: 6 months
|
Assessment tool: Patient Health Questionnaire (PHQ-8)
|
6 months
|
|
Is there an impact on anxiety through a palliative care intervention?
Zeitfenster: 6 months
|
Assessment tool: General Anxiety Disorder (GAD-7)
|
6 months
|
|
Is there an impact on cost of treatment through a palliative care intervention?
Zeitfenster: 6 months
|
Focus will be on cost through health care utilization as aggregated by number of hospital days, days in ICU and 30 day re-admissions.
|
6 months
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Akshay S Desai, MPH, MD, Brigham and Women's Hospital
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2014P001391
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Herzfehler
-
Region SkaneAnmeldung auf EinladungHerzinsuffizienz New York Heart Association (NYHA) Klasse II | Herzinsuffizienz New York Heart Association (NYHA) Klasse IIISchweden
-
Medical University of BialystokMedical University of Lodz; Poznan University of Medical Sciences; Nicolaus Copernicus... und andere MitarbeiterBeendetHerzinsuffizienz, systolisch | Herzinsuffizienz mit reduzierter Ejektionsfraktion | Herzinsuffizienz New York Heart Association Klasse IV | Herzinsuffizienz New York Heart Association Klasse IIIPolen
-
China National Center for Cardiovascular DiseasesChinese Academy of Medical Sciences, Fuwai HospitalAktiv, nicht rekrutierendLungenentzündung | Sepsis | Infektion | Driveline Heart-assisted Device Related InfectionChina
-
University of WashingtonAmerican Heart AssociationAbgeschlossenHerzinsuffizienz, kongestive | Mitochondriale Veränderung | Herzinsuffizienz New York Heart Association Klasse IVVereinigte Staaten
-
Abbott Medical DevicesThoratec CorporationAbgeschlossenDriveline Heart-assisted Device Related InfectionVereinigte Staaten
-
Portuguese Association of Interventional CardiologyMedtronicRekrutierungSchwere symptomatische Aortenstenose (definiert als New York Heart Association (NYHA) Klasse ≥ II)Portugal
-
University Hospital, GasthuisbergUnbekanntTransient Left Ventricular Ballooning SyndromeBelgien
-
Medical University of South CarolinaAmerican Heart AssociationAbgeschlossenSingle Ventricle Heart Disease nach Fontan-OperationVereinigte Staaten
-
NYU Langone HealthRekrutierungTako-Tsubo-Kardiomyopathie | Takotsubo-Kardiomyopathie | Broken-Heart-SyndromVereinigte Staaten
-
Mezzion Pharma Co. LtdNational Heart, Lung, and Blood Institute (NHLBI); Pediatric Heart NetworkAbgeschlossenSingle Ventricle Heart Disease nach Fontan-OperationVereinigte Staaten, Kanada
Klinische Studien zur Control
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...BeendetEmpfängnisverhütung | Nutzung des Gesundheitswesens | Verwendung von VerhütungsmittelnVereinigte Staaten
-
Shanghai Eye Disease Prevention and Treatment CenterAktiv, nicht rekrutierend
-
Cairo UniversityNoch keine Rekrutierung
-
University of California, San DiegoNational Cancer Institute (NCI); National Institutes of Health (NIH)AbgeschlossenInaktivitätVereinigte Staaten
-
Northwestern UniversityAbgeschlossen
-
Tandem Diabetes Care, Inc.RekrutierungDiabetes mellitus, Typ 1Frankreich
-
Evidence-Based Practice Institute, Seattle, WANational Institute of Mental Health (NIMH); University of MarylandAbgeschlossenVerhaltensstörungen bei Kindern | Selbstmord und SelbstverletzungVereinigte Staaten
-
University of Southern MississippiMilitary Suicide Research ConsortiumAnmeldung auf EinladungSuizidgedanken | AngstempfindlichkeitVereinigte Staaten
-
Medical University of South CarolinaMedtronic; Society of Urodynamics, Female Pelvic Medicine & Urogenital ReconstructionRekrutierung
-
W.L.Gore & AssociatesAbgeschlossenThoraxerkrankungenSchweden, Niederlande, Spanien, Deutschland, Frankreich, Vereinigtes Königreich, Italien